Back to today’s briefing

Story perspectives

UCL's MindGlide AI Revolutionizes Multiple Sclerosis Treatment Assessment

4/7/2025

50 4

Summary

Story summary

University College London's groundbreaking AI tool, MindGlide, is revolutionizing the assessment of multiple sclerosis (MS) treatments. By analyzing over 14,000 MRI scans, it swiftly identifies brain damage and lesions, surpassing existing methods. This innovative technology promises to harness valuable clinical data, paving the way for improved evaluations and outcomes in MS care.

1 of 1

Story summary

University College London's groundbreaking AI tool, MindGlide, is revolutionizing the assessment of multiple sclerosis (MS) treatments. By analyzing over 14,000 MRI scans, it swiftly identifies brain damage and lesions, surpassing existing methods. This innovative technology promises to harness valuable clinical data, paving the way for improved evaluations and outcomes in MS care.